A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability

• Asıl Yazarlar: Daniela Chirio (Yazar), Elena Peira (Yazar), Simona Sapino (Yazar), Giulia Chindamo (Yazar), Simonetta Oliaro-Bosso (Yazar), Salvatore Adinolfi (Yazar), Chiara Dianzani (Yazar), Francesca Baratta (Yazar), Marina Gallarate (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2021-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Bevacizumab (BVZ) is a monoclonal antibody that binds to human vascular endothelial growth factor A (VEGF-A) and inhibits the interaction between VEGF-A and VEGF receptors, thus blocking the angiogenesis. Repeated intravitreal injections of BVZ for the treatment of ocular pathologies that present an...